Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

被引:36
作者
Galve, E
Mallol, A
Catalan, R
Palet, J
Méndez, S
Nieto, E
Diaz, A
Soler-Soler, J
机构
[1] Hosp Gen Hosp Hebron, Serv Cardiol, Barcelona 08035, Spain
[2] Hosp Gen Univ Hebron, Serv Bioquim, Barcelona, Spain
关键词
heart failure; diuretics; neurohumoral activation;
D O I
10.1016/j.ejheart.2004.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms. Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure. Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]< 45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months. Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2 +/- 10.8 to 39.2 +/- 10.1 mg/dl at 3 months, p=0.014; creatinine 1.1 +/- 0.23 to 0.98 +/- 0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151 91 to 122 +/- 14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80 +/- 10 to 87 +/- 13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19 +/- 5.96 to 2.88 +/- 4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115 +/- 87 to 168 +/- 155 pg/ml, p=0.004). Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased. (c) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
[31]   Discharge risk scoring method for predicting mortality in hospitalized chronic heart failure patients with severe systolic dysfunction [J].
Tokatli, Alptug ;
Karauzum, Kurtulus ;
Ural, Dilek ;
Baydemir, Canan ;
Kozdag, Guliz ;
Celikyurt, Umut ;
Akay, Yasar ;
Argan, Onur ;
Yilmaz, Irem ;
Vural, Ahmet .
ACTA CARDIOLOGICA, 2015, 70 (04) :442-449
[32]   Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF [J].
Mentz, Robert J. ;
Fiuzat, Mona ;
Wojdyla, Daniel M. ;
Chiswell, Karen ;
Gheorghiade, Mihai ;
Fonarow, Gregg C. ;
O'Connor, Christopher M. .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (04) :395-403
[33]   Clinical phenotypes according to diuretic combination in acute heart failure [J].
Lopez-Vilella, Raquel ;
Pastor, Pablo Jover ;
Trenado, Victor Donoso ;
Sanchez-Lazaro, Ignacio ;
Dolz, Luis Martinez ;
Bonet, Luis Almenar .
HELLENIC JOURNAL OF CARDIOLOGY, 2023, 73 :1-7
[34]   Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function.: Do they differ in systolic dysfunction? [J].
Ojeda, S ;
Anguita, M ;
Muñoz, JF ;
Rodríguez, MT ;
Mesa, D ;
Franco, M ;
Ureña, I ;
Vallés, F .
REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (11) :1050-1056
[35]   Contribution of Ventricular Diastolic Dysfunction to Pulmonary Hypertension Complicating Chronic Systolic Heart Failure [J].
Miller, Wayne L. ;
Mahoney, Douglas W. ;
Michelena, Hector I. ;
Pislaru, Sorin V. ;
Topilsky, Yan ;
Enriquez-Sarano, Maurice .
JACC-CARDIOVASCULAR IMAGING, 2011, 4 (09) :946-954
[36]   Effectiveness of β-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease [J].
Chang, Tara I. ;
Yang, Jingrong ;
Freeman, James V. ;
Hlatky, Mark A. ;
Go, Alan S. .
JOURNAL OF CARDIAC FAILURE, 2013, 19 (03) :176-182
[37]   Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure [J].
Tang, W. H. Wilson ;
Wang, Zeneng ;
Shrestha, Kevin ;
Borowski, Allen G. ;
Wu, Yuping ;
Troughton, Richard W. ;
Klein, Allan L. ;
Hazen, Stanley L. .
JOURNAL OF CARDIAC FAILURE, 2015, 21 (02) :91-96
[38]   Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction [J].
Udelson, JE ;
Konstam, MA .
JOURNAL OF CARDIAC FAILURE, 2002, 8 (06) :S465-S471
[39]   Pharmacokinetics of Ibutilide in Patients with Heart Failure Due to Left Ventricular Systolic Dysfunction [J].
Tisdale, James E. ;
Overholser, Brian R. ;
Sowinski, Kevin M. ;
Wroblewski, Heather A. ;
Amankwa, Kwadwo ;
Borzak, Steven ;
Kingery, Joanna R. ;
Coram, Rita ;
Zipes, Douglas P. ;
Flockhart, David A. ;
Kovacs, Richard J. .
PHARMACOTHERAPY, 2008, 28 (12) :1461-1470
[40]   In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function [J].
De Vecchis, R. ;
Ciccarelli, A. ;
Ariano, C. ;
Cioppa, C. ;
Giasi, A. ;
Pucciarelli, A. ;
Cantatrione, S. .
MINERVA CARDIOANGIOLOGICA, 2011, 59 (06) :543-554